secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0001493152-23-023975
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.03, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX Therapeutics draws $500,000 under secured convertible note due Feb 2024
----------------------------------------------------------------------------

- Drew $500,000 from credit available under Secured Note on July 5, 2023.
- Outstanding principal balance due and payable on February 14, 2024.
- Other material terms of the Secured Note previously filed in Form 10-Q and Form 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223023975/0001493152-23-023975-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223023975/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-023975

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer